Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

Abstract

Our findings indicate that UC MSCT results in amelioration of disease activity, serologic changes, and stabilization of proinflammatory cytokines. These data provide a foundation for conducting a randomized controlled trial of this new therapy for severe and treatment-refractory SLE.